IBIO, INC. Company Profile
IBIO, INC. as SEC EDGAR records it: incorporation, addresses, industry, fiscal year end, filer category and former names.
- Current registered country: Value Delaware, United States.
- Country of operation (business address): Value United States.
- Business address: Value 600 MADISON AVENUE, SUITE 1601, NEW YORK, New York, 10022-1737, United States.
- Mailing address: Value 600 MADISON AVENUE, SUITE 1601, NEW YORK, New York, 10022-1737, United States.
| Measure | Value |
|---|---|
| Current registered country | Delaware, United States SEC EDGAR state of incorporation DE |
| Country of operation (business address) | United States |
| Business address | 600 MADISON AVENUE, SUITE 1601, NEW YORK, New York, 10022-1737, United States |
| Mailing address | 600 MADISON AVENUE, SUITE 1601, NEW YORK, New York, 10022-1737, United States |
| Industry (SIC) | 2834 Pharmaceutical Preparations |
| Fiscal year end | 06-30 |
| Filer category | Non-accelerated filer<br>Smaller reporting company |
| Listed stock (Section 12(b)) | Common Stock · IBIO · NASDAQ 10-K filed 2026-08-28 cover |
| Shell company | No 10-K filed 2026-08-28 cover |
| Smaller reporting company | Yes 10-K filed 2026-08-28 cover |
| Emerging growth company | No 10-K filed 2026-08-28 cover |
| Well-known seasoned issuer | No 10-K filed 2026-08-28 cover |
| Voluntary filer | No 10-K filed 2026-08-28 cover |
| Current in its reporting | Yes 10-K filed 2026-08-28 cover |
| Former names | iBio, Inc. (2009-08-18 to 2026-09-14) iBioPharma, Inc. (2008-07-16 to 2009-08-14) InB:Biotechnologies, Inc. (2008-03-07 to 2008-07-17) |
| First EDGAR filing | 2008-03-07 (10-12G) |
| SEC CIK | 1420720 |
| EIN | 262797813 |
| Phone | 302 355-0650 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |